Evidence map›Paper›PMID 32867357›Full record

ReviewInternational journal of molecular sciences2020

Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.

Ha Thi Thu Do, Jungsook Cho

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. AdjunctiveCanadian journal of psychiatry. Revue canadienne de psychiatrie · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. ACS pharmacology & translational science · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Effects of the Bark Resin Extract ofMolecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ha Thi Thu DoCollege of Pharmacy, Dongguk University-Seoul, Dongguk-ro 32, Ilsandong-gu, Goyang, Gyeonggi 10326, Korea.
Jungsook ChoCollege of Pharmacy, Dongguk University-Seoul, Dongguk-ro 32, Ilsandong-gu, Goyang, Gyeonggi 10326, Korea.
Dongguk University · KR

Funding

National Research Foundation of Korea NRF-2018R1A5A2023127
6 · The paper itself

Abstract

Alzheimer's disease (AD), Parkinson's disease (PD), and depression are growing burdens for society globally, partly due to a lack of effective treatments. Mangosteen (

Indexed as

alpha-SynucleinAlzheimer DiseaseAminesAmyloid beta-PeptidesAnimalsDepressionGarcinia mangostanaHumansNeurodegenerative DiseasesParkinson DiseasePlant ExtractsXanthonesalpha-SynucleinAminesAmyloid beta-PeptidesPlant ExtractsXanthonesAlzheimer’s diseasedepressionmangosteen (Garcinia mangostana L.) pericarpneurodegenerative diseasesParkinson’s diseasepharmacokineticssafetyα-mangostinγ-mangostin

Identifiers

PMID32867357
PMCPMC7504283
OpenAlexW3081102492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.